Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.06
+0.21 (3.07%)
At close: Jun 26, 2026, 4:00 PM EDT
7.08
+0.02 (0.28%)
After-hours: Jun 26, 2026, 5:04 PM EDT
Seres Therapeutics Employees
Seres Therapeutics had 66 employees as of December 31, 2025. The number of employees decreased by 37 or -35.92% compared to the previous year.
Employees
66
Change (1Y)
-37
Growth (1Y)
-35.92%
Revenue / Employee
$17,379
Profits / Employee
-$710,591
Market Cap
68.56M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| XBiotech | 87 |
| Acrivon Therapeutics | 76 |
| Pliant Therapeutics | 49 |
| BeyondSpring | 44 |
| eXoZymes | 32 |
| Entera Bio | 22 |
| Edesa Biotech | 17 |
| ImageneBio | 17 |
MCRB News
- 3 days ago - Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres' SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis - GlobeNewsWire
- 5 days ago - Seres Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 23 days ago - Seres Therapeutics announces two transactions - TheFly
- 23 days ago - Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027 - GlobeNewsWire
- 5 weeks ago - Seres Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 6 weeks ago - Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference - GlobeNewsWire
- 7 weeks ago - Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - Seres Therapeutics Earnings release: Q1 2026 - Filings